Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CATVOTCMKTS:FFNTFOTCMKTS:TGIFFOTCMKTS:VYYRF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCATV4Cable TV International$0.00$0.00$0.00▼$0.00N/AN/A41.85 million shs10.25 million shsFFNTF4Front Ventures$0.00+25.0%$0.00$0.00▼$0.11N/AN/A1.52 million shs7.40 million shsTGIFF1933 Industries$0.00+4.3%$0.00$0.00▼$0.01N/AN/A135,893 shs14,300 shsVYYRFVoyageur Pharmaceuticals$0.20-9.1%$0.15$0.00▼$0.25N/AN/A57,890 shs1,040 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCATV4Cable TV International0.00%0.00%0.00%0.00%-76.00%FFNTF4Front Ventures0.00%+700.00%+433.33%-81.82%-97.95%TGIFF1933 Industries0.00%-14.55%+4.44%+38.24%-50.53%VYYRFVoyageur Pharmaceuticals0.00%-8.33%+60.58%+175.00%+214.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCATV4Cable TV InternationalN/AN/AN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/AN/AN/AVYYRFVoyageur PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCATV4Cable TV International 0.00N/AN/AN/AFFNTF4Front Ventures 0.00N/AN/AN/ATGIFF1933 Industries 0.00N/AN/AN/AVYYRFVoyageur Pharmaceuticals 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCATV4Cable TV InternationalN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/AVYYRFVoyageur PharmaceuticalsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCATV4Cable TV InternationalN/A-$0.01N/A∞N/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/A0.00∞N/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/A0.00∞N/AN/AN/AN/AN/AVYYRFVoyageur PharmaceuticalsN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCATV4Cable TV InternationalN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AVYYRFVoyageur PharmaceuticalsN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCATV4Cable TV InternationalN/AFFNTF4Front VenturesN/ATGIFF1933 IndustriesN/AVYYRFVoyageur PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipCATV4Cable TV InternationalN/AFFNTF4Front VenturesN/ATGIFF1933 IndustriesN/AVYYRFVoyageur PharmaceuticalsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCATV4Cable TV International10N/AN/ANot OptionableFFNTF4Front Ventures460N/AN/ANot OptionableTGIFF1933 Industries87N/AN/ANot OptionableVYYRFVoyageur PharmaceuticalsN/AN/AN/ANot OptionableVYYRF, TGIFF, CATV, and FFNTF HeadlinesRecent News About These CompaniesVoyageur Pharmaceuticals signs LOI for Latin American distribution partnershipJune 24, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals Signs LOI for Latin America Distribution Partnership Supporting Global Market ExpansionJune 24, 2025 | thenewswire.comTVoyageur Pharmaceuticals advances iodine-based pharma manufacturing strategy with Altillion collaborationJune 23, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals books first commercial sale with barium contrast agents orderJune 4, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals appoints executive vice president to lead market expansion initiativesMay 13, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice PresidentMay 12, 2025 | thenewswire.comTVoyageur Pharmaceuticals unveils leadership changesMay 1, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals Announces Changes to Board of Directors and DSU GrantMay 1, 2025 | thenewswire.comTVoyageur Pharmaceuticals launches contrast media product line following successful clinical resultsApril 23, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals Grants Deferred Share UnitsApril 7, 2025 | thenewswire.comTVoyageur Pharmaceuticals nears Canadian market launch with completion of human testingApril 1, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals launches Frances Creek barium contrast media projectMarch 5, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product LineMarch 4, 2025 | thenewswire.comTVoyageur Clarifies Terms of Previously Announced AgreementMarch 3, 2025 | newsfilecorp.comNVoyageur Pharmaceuticals Strengthens Governance with DSU IssuanceFebruary 24, 2025 | tipranks.comVoyageur Pharmaceuticals Grants Deferred Share UnitsFebruary 24, 2025 | thenewswire.comTVoyageur Pharmaceuticals launches MRI drug development programFebruary 18, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals secures grant to advance barium sulfate project - ICYMIFebruary 8, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals secures Alberta grant to advance barium contrast projectFebruary 5, 2025 | proactiveinvestors.comVoyageur Pharmaceuticals exercises warrants to secure additional capitalJanuary 24, 2025 | proactiveinvestors.comMedia Sentiment Over TimeVYYRF, TGIFF, CATV, and FFNTF Company Descriptions4Cable TV International OTCMKTS:CATV$0.0003 0.00 (0.00%) As of 03:59 PM Eastern4Cable TV International, Inc. provides specialty solutions to the cable television sector. It offers a suite of products comprising RF to Fiber (RF2F), a proprietary line of coax-to-fiber taps that enables cable operators to reach homes within their franchise authorized area; PowerMiser, a circuitry, which allows a low current 1 GHz amplifier and/or line extender to be constructed with a decrease in current power requirements; RF over Glass (RFoG) signal distribution technology that combines the existing cable TV infrastructure with fiber optics to reach the home; and Node+0 application, which combines the RFoG technology platform with its PowerMiser engineering to take fiber signal. The company also provides SOLAR-CATV that utilizes solar power and helps the operator extend service to areas not presently served without adding power sources; and Dynamically Scalable Return technology, which allows nodes, R-ONU's (RFoG optical network units) to adjust their return bandwidth by changing the channel lineup at the head end, as well as repair, testing, and upgrade services. It markets and sells its products through a network of dealers in the United States and Canada primarily to independent cable TV operators, as well as to multiple system operators. 4Cable TV International, Inc. was incorporated in 2007 and is based in Conway, South Carolina.4Front Ventures OTCMKTS:FFNTF$0.0020 +0.00 (+25.00%) As of 03:58 PM Eastern4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.1933 Industries OTCMKTS:TGIFF$0.0049 +0.00 (+4.26%) As of 03:34 PM Eastern1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada.Voyageur Pharmaceuticals OTCMKTS:VYYRF$0.20 -0.02 (-9.09%) As of 03:23 PM EasternVoyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah. It develops barium, iodine-based APIs, and imaging contrast agents for medical radiology. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
